菱形黑钻贫血综合征红系生成缺陷的脂代谢转录组特征
该研究利用Rpl5Skax23-Jus/+小鼠模型解析DBAS可变贫血表型机制,发现该剪接突变致病并致部分内含子保留。E12.5胎肝红系祖细胞转录组显示红系分化通路下调及脂代谢基因失调,Scd1表达显著降低。成年突变鼠贫血恢复延迟,Scd1抑制剂预处理可改善野生型与突变型红系生成。
要点
- Rpl5Skax23-Jus/+小鼠重现DBAS可变颅面心脏缺陷,剪接突变为致病性。
- E12.5突变胚胎红系祖细胞脂代谢转录失调,Scd1表达显著降低。
- Scd1抑制剂预处理改善野生型和突变型小鼠红系生成。
核心结论
- 脂代谢可能参与DBAS可变贫血外显率,Scd1通路是待研究药物靶点。
研究设计与样本
- 采用已建立的Rpl5Skax23-Jus/+小鼠DBAS模型研究动态红系生成缺陷。
- 分析E12.5胎肝红系祖细胞转录组及成年鼠贫血诱导实验。
主要发现
- 该杂合剪接突变致病并导致部分内含子保留。
- E12.5突变胚胎红系分化通路下调,符合DBAS表型。
- E12.5突变胚胎亚群中Scd1表达显著降低,脂代谢基因转录失调。
- 成年突变鼠贫血诱导后红系恢复延迟。
- Scd1抑制剂预处理改善野生型和突变型小鼠红系生成。
临床怎么用
- DBAS贫血评估可关注脂代谢转录特征,尤其Scd1表达。
- Scd1抑制作为改善红系生成的潜在策略需进一步临床前研究。
局限性
- 研究基于小鼠模型,结论外推至DBAS患者需谨慎。
- Scd1与红系生成或DBAS的关联此前未见报道,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Analysis of Diamond Blackfan anemia syndrome (DBAS) cohorts and animal models has not revealed a potential mechanism for the variable anemia phenotype, a key feature of this disease. Here, we used an established Rpl5Skax23-Jus/+ murine DBAS model to study this dynamic erythropoiesis deficiency. These haploinsufficient mice exhibit variably penetrant craniofacial and cardiac defects mimicking the phenotypes of patients with DBAS bearing RPL5 mutations. We additionally discovered that this specific heterozygous splicing mutation is pathogenic and leads to partial intron retention. By examining the transcriptome of fetal liver erythroid progenitors at embryonic day 12.5 (E12.5), we demonstrate downregulation of erythroid differentiation pathways consistent with the DBAS phenotype. We also identified dysregulated transcription of lipid metabolism genes with significant reduction in Scd1 expression in the subset of E12.5 mutant embryos at risk for erythroid failure. Stearoyl-coenzyme A desaturase 1, a key enzyme that converts saturated to monounsaturated fatty acids, has not been previously linked to erythropoiesis or DBAS. When anemia was induced in adult Rpl5Skax23-Jus/+ mice, mutant mice exhibited delayed erythroid recovery, whereas pretreatment with an stearoyl-coenzyme A desaturase 1 inhibitor resulted in improved erythropoiesis in both wild-type and mutant mice. This analysis suggests a potential role of lipid metabolism in the variable anemia penetrance in DBAS and highlights a previously unappreciated pathway that requires further study as a potential target for drug development.
引用
- Deng K, Wang Y, Min JC, et al. Lipid metabolism transcriptomic signature of defective erythropoiesis in Diamond Blackfan anemia syndrome. Blood Adv. 2026. PMID: 41576344. doi:10.1182/bloodadvances.2025017318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。